Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

sodium glycerophosphate

sodium glycerophosphate
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Glycophos SOLUTION, INTRAVENOUS 4.32 g/20 mL      
VIEW MORE Other Miscellaneous Therapeutic Agents
CLASS
929200
Comments:

GLYCOPHOS Information - DI Question

Glycophos is an imported intravenous phosphate replacement product, approved by the FDA temporarily during the current phosphate product shortage. Glycophos should not be mixed with other drugs or added to TPN due to limited compatibility information.

Reviewed: November 19, 2013 (Glycophos)

Last updated: Jul. 6, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved